Please join us for our September Chapter meeting sponsored by Portola Pharmaceuticals and Andexxa! Ben A. Fickenscher MD, F-ACEP, F-AAEM will be joining us to talk about Andexxa, the first and only specific reversal agent for apixaban- and rivaroxaban-treated patients with life-threatening or uncontrolled bleeding. Dinner will be provided.
**Please register for this meeting since space is limited. Members will get priority registration**